Millie Ray, PhD
InvestorPartner at The Column Group
Find your path to Millie
29 people in our graph share verified history with Millie — schools, employers, funds. One of them is your warm intro.
Tim KutzkeyunlockedMillie: together at The Column Group
×11Millie: together at The Column Group
About
Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
David Goeddel
Managing Partner at The Column Group
David V. Goeddel, Ph.D.
General Partner at The Column Group
David V. Goeddel, PhD
Partner Emeritus at The Column Group
Hui Tian
Partner at The Column Group
Frequently asked questions
- Who is Millie Ray, PhD?
- Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
- Where does Millie Ray, PhD work?
- Millie Ray, PhD is Partner at The Column Group.
- What does Millie Ray, PhD invest in?
- Millie Ray, PhD invests in Biotech, Healthtech.